117th Congress · HOUSE BILLBILL

H.R. 6513 — Medical Innovation Acceleration Act of 2022

“To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.”

Health

Introduced Jan 28, 2022

Last action Jan 31, 2022

Pipeline · Bill → Law

Step 1

Introduced

Jan 28, 2022

Step 2

Referred

Jan 31, 2022

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Jan 31, 2022

Referred to the Subcommittee on Health.

Jan 28, 2022

Introduced in House

Jan 28, 2022

Referred to the House Committee on Energy and Commerce.